CYTK: Cytokinetics, Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6,639.53
Enterprise Value ($M) 6,642.15
Book Value ($M) -386.32
Book Value / Share -3.69
Price / Book -17.19
NCAV ($M) -582.59
NCAV / Share -5.56
Price / NCAV -11.40

Profitability (mra)
Return on Invested Capital (ROIC) -1.42
Return on Assets (ROA) -0.59
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 6.12
Current Ratio 6.12

Balance Sheet (mrq) ($M)
Current Assets 628.05
Assets 824.32
Liabilities 1,210.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.53
Operating Income -496.20
Net Income -526.24
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -414.33
Cash from Investing 239.25
Cash from Financing 221.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 11.24 9.37
02-09 13G/A Fmr Llc 13.27 -2.99
02-08 13G/A Wellington Management Group Llp 6.66 -0.18
01-25 13G/A State Street Corp 6.01 16.82
01-22 13G/A BlackRock Inc. 16.40 2.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 74,118 446,932 16.58
2024-05-01 147,802 1,019,806 14.49
2024-04-30 110,327 1,034,378 10.67
2024-04-29 210,202 456,627 46.03

(click for more detail)

Similar Companies
CRGX – CARGO Therapeutics, Inc. CRNX – Crinetics Pharmaceuticals, Inc.
CTMX – CytomX Therapeutics, Inc. DAWN – Day One Biopharmaceuticals, Inc.
DCPH – Deciphera Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io